Compare AFLAC Incorporated (AFL) vs BioNano Genomics Inc (BNGO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AFLAC Incorporated vs BioNano Genomics Inc — how do they compare? AFLAC Incorporated trades at $121.41 (market cap $61.84B), while BioNano Genomics Inc trades at $1.14 (market cap $13.08M). The key difference: AFLAC Incorporated is far larger — about 4727.8× BioNano Genomics Inc's market cap, and AFLAC Incorporated pays a 2.01% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| AFL | BNGO | |
|---|---|---|
Market Cap | $61.84B | $13.08M |
Sector | Financials | Health |
52-Week High | $121.49 | $4.92 |
52-Week Low | $98.09 | $1.09 |
Enterprise Value | $70.50B | $15.69M |
Dividend Yield | 2.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in the two largest insurance markets in the world, the U.S. and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accidents, disability, and long-term-care insurance. It markets its products through independent distributors, selling most of its policies directly to consumers at their places of work.
Read more on AFL →About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →
